FCH
CLB icon

Freestone Capital Holdings’s Core Laboratories CLB Stock Holding History

Freestone Capital Holdings’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-47,347
Closed -$1.5M – 461
2022
Q1 		$1.5M Sell
47,347
-286
-0.6% -$8.02K 0.06% 213
2021
Q4 		$1.06M Buy
+47,633
New +$1.24M 0.04% 229
2021
Q1 		– Sell
-25,000
Closed -$663K – 513
2020
Q4 		$663K Buy
25,000
+15,000
+150% +$306K 0.04% 223
2020
Q3 		$153K Hold
10,000
– – 0.01% 359
2020
Q2 		$203 Hold
10,000
– – ﹤0.01% 329
2020
Q1 		$103 Buy
+10,000
New +$280K ﹤0.01% 360
2016
Q1 		– Sell
-2,903
Closed -$316K – 334
2015
Q4 		$316K Sell
2,903
-946
-25% -$108K 0.03% 296
2015
Q3 		$384K Buy
3,849
+516
+15% +$56.1K 0.04% 264
2015
Q2 		$380K Buy
3,333
+124
+4% +$15K 0.06% 185
2015
Q1 		$335K Buy
3,209
+955
+42% +$102K 0.05% 152
2014
Q4 		$271K Sell
2,254
-633
-22% -$83.1K 0.04% 154
2014
Q3 		$423K Buy
2,887
+186
+7% +$28.7K 0.07% 116
2014
Q2 		$451K Buy
2,701
+239
+10% +$42.5K 0.07% 143
2014
Q1 		$489K Buy
2,462
+983
+66% +$186K 0.09% 126
2013
Q4 		$282K Buy
1,479
+88
+6% +$16.4K 0.05% 232
2013
Q3 		$236K Buy
+1,391
New +$216K 0.04% 302

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Freestone Capital Holdings's CLB Position: Q2 2022 in Review

Freestone Capital Holdings sold out of Core Laboratories (CLB) in Q2 2022, closing a stake of 47,347 shares — an estimated $1.5M sold.

Freestone Capital Holdings first reported a position in CLB in Q3 2013 and held it in 16 quarters. The position peaked at $1.5M in Q1 2022. 176 funds tracked by Wall St. Rank hold CLB as of Q2 2022.

  • Freestone Capital Holdings reported no remaining Core Laboratories position as of Q2 2022 after selling out during the quarter.
  • Freestone Capital Holdings sold 47,347 Core Laboratories shares in Q2 2022, an estimated $1.5M.
  • Freestone Capital Holdings first reported a position in Core Laboratories in Q3 2013 and held it in 16 quarters.
  • Freestone Capital Holdings's Core Laboratories position peaked at $1.5M in Q1 2022.
  • 176 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2022.

Based on Freestone Capital Holdings's 13F filing for Q2 2022, filed 9 Aug 2022.